Official websites use. Share sensitive information only on official, secure websites. Correspondence to: Khalil El Karoui; E-mail: khalil. Correspondence to: Philippe Attias; E-mail: attias. For commercial re-use, please contact journals. However, long-term consequences of this disease in the MHD population are poorly described. Overall, cardiovascular events, infections and gastrointestinal bleeding were the main major adverse events.
Lower initial albuminaemia was significantly associated with this cachexia. No reinfection with severe acute respiratory syndrome coronavirus 2 was observed. This work demonstrates the long-term consequences of COVID in MHD patients, highlighting both initial and long-term severity of the disease, including severe cachexia.
A new type of coronavirus, severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 , emerged in December , causing coronavirus disease COVID , which rapidly spread to a global public health emergency [ 1 , 2 ]. Maintenance haemodialysis MHD patients have a high risk of initial mortality from the disease [ 3—6 ].
Overall, patients are managed in these facilities. Relevant clinical, laboratory and outcome data were retrospectively reported. Data were recorded at diagnosis when available or during follow-up. Management of patients [including renin—angiotensin system RAS blockade discontinuation or not] was performed according to the judgement of the treating physician.
Previous immunosuppressive treatment included ongoing use of steroids, biotherapy and chemotherapies. The clinical outcomes were monitored up to 30 September Major adverse events included cardiovascular events myocardial infarction, stroke, acute peripheral artery disease, pulmonary embolism or cardiac arrest or severe infections needing hospitalization or prolonged antibiotherapy or other events requiring hospitalization.
